NCT06562023View on ClinicalTrials.gov

Botulinum Toxin and Mesotherapy on Enhancement of Facial Scarring

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 19, 2022

Primary Completion Date

July 20, 2024

Study Completion Date

July 20, 2024

Conditions
Facial Scars
Interventions
OTHER

Botulinum Toxin Type A

Patients will receive BTA injection within a period of 5 days after primary closure.

OTHER

Mesotherapy

Patients will receive mesotherapy growth factor serum with a derma pen within a period of 5 days after primary closure.

Trial Locations (1)

Unknown

Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Alexandria

All Listed Sponsors
lead

Hams Hamed Abdelrahman

OTHER